
 |

Lawrence Brass, M.D. Ph.D.
Medline
search 
Professor of Medicine, Pathology and
Pharmacology
Associate Director, Center for Experimental Therapeutics
Associate Dean and Director, Combined
Degree and Physician Scholars Programs, University of Pennsylvania,
School of Medicine
Member, Graduate Group in Pharmacological Sciences
Member, Cell and Molecular Biology Graduate Group
Member, Biochemistry and Molecular Biophysics Graduate Group
Ph.D. (Biochemistry), 1975, Case Western Reserve University
M.D., 1977, Case Western Reserve University
Biomedical
Research 2 (BRB II/III), Rm. 913
421 Curie Blvd.
Philadelphia, PA 19104-6160
215-573-3540 phone
215-573-2189 fax
Research:
The studies in my laboratory focus
on the molecular mechanisms underlying vascular biology and pathology.
Despite major medical advances over the past 20 years, atherosclerotic
cardiovascular disease and vascular thrombosis remain among the major
causes of death and chronic illness in the United States. Our studies
are directed toward understanding the intracellular events that underlie
these disorders in vascular cells. To do this, we study the molecular
mechanisms of signal transduction that allow platelets to respond to extracellular
events. A variety of approaches are being used included transgenic and
knockout mouse models.
Topics that we currently have under
investigation include: 1) Protease-activated G protein coupled receptors,
including the thrombin receptor. These are a widely-expressed family of
receptors that are activated by proteases. Three family members have been
described to date. Our work focuses on the identification of additional
family members, the signalling pathways that are initiated when these
receptors are activated, the trafficking of the receptors within the cell
as used receptors are replaced, and the development of receptor antagonists
and clinically-useful assays for detecting receptor activation in vivo.
2) The role of the G protein, Gz.
G proteins are molecular switches that activate or retard the intracellular
events that regulate cell function. Although most G proteins are expressed
in most tissues, a few are expressed only in a limited number of tissues.
Gz
is one of the G proteins that are not universally expressed, its presence
being limited mainly to some neural cells and to some hematopoietic cells,
particularly megakaryocytes and platelets. We have recently completed
the development of mice that lack the a
subunit of Gz. These mice have a disorder of platelet function that is
able to protect them from the mortality and morbidity in acute thrombosis
models. 3)
The role in platelet activation and endothelial cell biology of Eph
tyrosine kinase receptors and their ligands, which are known as ephrins.
Eph receptors are a large family of membrane-bound tyrosine kinases whose
function is largely unknown. Recent studies have shown that interactions
between Eph receptors and their ligands play an important role in the
developing central nervous system. Our interest lies in their potential
role in the vascular wall, participating in interactions that occur when
platelets, endothelial cells and leukocytes encounter each other.
Keywords: vascular biology, thrombosis,
atherosclerosis, signal transduction, platelets, endothelial cells, G
protein coupled receptors, integrins.
Recent references
Peter J. O’Brien, Nicolas Prevost,
Marina Molino, M. Katherine Hollinger, Marilyn J. Woolkalis, Donna S.
Woulfe, and Lawrence F. Brass. Thrombin responses in human endothelial
cells: contributions from receptors other than PAR1 include the transactivation
of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275: 13502-13509, 2000.
J. Yang, J. Wu, M.A. Kowalska, A.
Dalvi, N. Prevost, P.J. O'Brien, D.R. Manning, M. Poncz, I. Lucki, J.A.
Blendy and L.F. Brass. Loss of signaling through the novel G protein,
Gz,
results in abnormal platelet activation and altered responses to psychoactive
drugs. Proc. Nat. Acad. Sci. 97: 9984-89, 2000.
Brass, L.F.: Small cells, big issues. Nature 409: 145-146, 2000.
Woulfe,D., Yang,J. and Brass,L.: ADP and platelets: the end of the beginning.
J. Clin. Invest. 107: 1503-1505, 2001.
P.J. O'Brien, M. Molino, M. Kahn and L. Brass: Protease-activated receptors:
theme and variations. Oncogene 20: 1570-1581, 2001.
Brass,L.F.: Platelets and proteases. Nature 413: 26-27, 2001.
D. Woulfe, H. Jiang, R. Mortensen, J. Yang and L.F. Brass. Activation
of Rap1B by Gi family members in platelets. J. Biol. Chem. 277: 23382-23390,
2002.
N. Prevost, D. Woulfe, T. Tanaka and L.F. Brass. Interactions between
Eph kinases and ephrins provide a novel mechanism to support platelet
aggregation once cell-to-cell contact has occurred. Proc. Nat. Acad.
Sci 99: 9219-9224, 2002.
Awards, Honors and Membership in Honorary Societies
Established Investigator, American Heart Association, 1985-90
American Society for Clinical Investigation, 1987
Excellence in Teaching Award, Penn Medical School Class of 1999, 1998
Outstanding Teaching Award, Penn Medical School Class of 2001, 1998
IXth Biennial Award for Contributions to Hemostasis Research, International
Society of Thrombosis and Hemostasis, 1999
Excellence in Teaching Award, Penn Medical School Class of 2002, 2000
Outstanding Course Director Award, Penn Med Class of 2003, 2001
Christian R. and Mary F. Lindback Foundation Award for Distinguished
Teaching, University of Pennsylvania, 2001
Outstanding Course Director Award, Penn Med Class of 2004, 2001
Editorial Boards
Journal of Biological Chemistry, 1994-1999
Journal of Biological Chemistry, 2001-2006
Blood, 1996-2001
Arteriosclerosis, Thrombosis and Vascular Biology, 1999-2000
Membership in National Scientific Review Panels
Merit Review Board in Hematology, U.S. Veterans Administration, 1987-1990
Chair, Merit Review Board in Hematology, U.S. Veterans Admin., 1989-1990
Vascular Biology Review Board, American Heart Association, 1988-1990
Hematology II Study Section, NIH HLBI, 1997-2000
Conference organization
Co-Chair, FASEB Conference on Thrombin and Vascular Medicine, 1997
Chair, Gordon Conference on Hemostasis, 2000
Chair, Committee on Platelets, American Society of Hematology, 2001
FASEB Conference on Proteases and Protease Receptors, 2005
|